Fulgent Genetics
FLGT
Fulgent Genetics (FLGT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Maintained | Neutral | $19.00 from $15.00 | Aug 4, 2026 |
| Piper Sandler | Maintained | Neutral | $15.00 from $30.00 | May 5, 2026 |
| Piper Sandler | Maintained | Neutral | $30.00 from $21.00 | Nov 11, 2025 |
| UBS | Upgraded | Neutral → Buy | $30.00 from $20.00 | Aug 5, 2025 |
| Piper Sandler | Maintained | Neutral | $21.00 from $23.00 | Aug 4, 2025 |
| Piper Sandler | Maintained | Neutral | $23.00 from $16.00 | May 6, 2025 |
| Raymond James | Maintained | Outperform | $25.00 from $24.00 | May 5, 2025 |
| Piper Sandler | Maintained | Neutral | $16.00 from $22.00 | Mar 4, 2025 |
| Piper Sandler | Maintained | Neutral | $22.00 from $26.00 | Nov 11, 2024 |
| Piper Sandler | Maintained | Neutral | $25.00 from $28.00 | Mar 6, 2024 |
| UBS | Initiated Coverage | Neutral | $35.00 | Dec 7, 2023 |
| Piper Sandler | Maintained | Neutral | $28.00 from $37.00 | Oct 16, 2023 |
Frequently asked questions
What is the latest analyst rating on FLGT?
On Aug 4, 2026, Piper Sandler maintained Fulgent Genetics at Neutral with a price target of $19.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.